These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23920437)

  • 1. Identification of quinazolinyloxy biaryl urea as a new class of SUMO activating enzyme 1 inhibitors.
    Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5145-9. PubMed ID: 23920437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of sumoylation activating enzyme 1 inhibitors by structure-based virtual screening.
    Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
    J Chem Inf Model; 2013 Apr; 53(4):809-20. PubMed ID: 23544417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designed semisynthetic protein inhibitors of Ub/Ubl E1 activating enzymes.
    Lu X; Olsen SK; Capili AD; Cisar JS; Lima CD; Tan DS
    J Am Chem Soc; 2010 Feb; 132(6):1748-9. PubMed ID: 20099854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new SUMO activating enzyme 1 inhibitors using virtual screening and scaffold hopping.
    Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1218-23. PubMed ID: 26810265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors.
    Holladay MW; Campbell BT; Rowbottom MW; Chao Q; Sprankle KG; Lai AG; Abraham S; Setti E; Faraoni R; Tran L; Armstrong RC; Gunawardane RN; Gardner MF; Cramer MD; Gitnick D; Ator MA; Dorsey BD; Ruggeri BR; Williams M; Bhagwat SS; James J
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5342-6. PubMed ID: 21807507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of novel ubiquitin-activating enzyme inhibitors.
    Itoh Y; Suzuki M
    Bioorg Med Chem Lett; 2018 Sep; 28(16):2723-2727. PubMed ID: 29548576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer.
    Langston SP; Grossman S; England D; Afroze R; Bence N; Bowman D; Bump N; Chau R; Chuang BC; Claiborne C; Cohen L; Connolly K; Duffey M; Durvasula N; Freeze S; Gallery M; Galvin K; Gaulin J; Gershman R; Greenspan P; Grieves J; Guo J; Gulavita N; Hailu S; He X; Hoar K; Hu Y; Hu Z; Ito M; Kim MS; Lane SW; Lok D; Lublinsky A; Mallender W; McIntyre C; Minissale J; Mizutani H; Mizutani M; Molchinova N; Ono K; Patil A; Qian M; Riceberg J; Shindi V; Sintchak MD; Song K; Soucy T; Wang Y; Xu H; Yang X; Zawadzka A; Zhang J; Pulukuri SM
    J Med Chem; 2021 Mar; 64(5):2501-2520. PubMed ID: 33631934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversification of SUMO-activating enzyme in Arabidopsis: implications in SUMO conjugation.
    Castaño-Miquel L; Seguí J; Manrique S; Teixeira I; Carretero-Paulet L; Atencio F; Lois LM
    Mol Plant; 2013 Sep; 6(5):1646-60. PubMed ID: 23482370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme.
    Lv Z; Yuan L; Atkison JH; Williams KM; Vega R; Sessions EH; Divlianska DB; Davies C; Chen Y; Olsen SK
    Nat Commun; 2018 Dec; 9(1):5145. PubMed ID: 30514846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO-mimicking peptides inhibiting protein SUMOylation.
    Zhao B; Villhauer EB; Bhuripanyo K; Kiyokawa H; Schindelin H; Yin J
    Chembiochem; 2014 Dec; 15(18):2662-6. PubMed ID: 25412743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors.
    Markwalder JA; Seitz SP; Blat Y; Elkin L; Hunt JT; Pabalan JG; Jure-Kunkel MN; Vite GD; Covello K
    Bioorg Med Chem Lett; 2017 Feb; 27(3):582-585. PubMed ID: 28003141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based identification of a NEDD8-activating enzyme inhibitor via drug repurposing.
    Wu KJ; Zhong HJ; Li G; Liu C; Wang HD; Ma DL; Leung CH
    Eur J Med Chem; 2018 Jan; 143():1021-1027. PubMed ID: 29232579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme.
    Li YJ; Du L; Wang J; Vega R; Lee TD; Miao Y; Aldana-Masangkay G; Samuels ER; Li B; Ouyang SX; Colayco SA; Bobkova EV; Divlianska DB; Sergienko E; Chung TDY; Fakih M; Chen Y
    Cell Chem Biol; 2019 Feb; 26(2):278-288.e6. PubMed ID: 30581133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Largazole and its derivatives selectively inhibit ubiquitin activating enzyme (e1).
    Ungermannova D; Parker SJ; Nasveschuk CG; Wang W; Quade B; Zhang G; Kuchta RD; Phillips AJ; Liu X
    PLoS One; 2012; 7(1):e29208. PubMed ID: 22279528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a natural product inhibitor targeting protein neddylation by structure-based virtual screening.
    Zhong HJ; Ma VP; Cheng Z; Chan DS; He HZ; Leung KH; Ma DL; Leung CH
    Biochimie; 2012 Nov; 94(11):2457-60. PubMed ID: 22709868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heteroaryl urea inhibitors of fatty acid amide hydrolase: structure-mutagenicity relationships for arylamine metabolites.
    Tichenor MS; Keith JM; Jones WM; Pierce JM; Merit J; Hawryluk N; Seierstad M; Palmer JA; Webb M; Karbarz MJ; Wilson SJ; Wennerholm ML; Woestenborghs F; Beerens D; Luo L; Brown SM; Boeck MD; Chaplan SR; Breitenbucher JG
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7357-62. PubMed ID: 23141911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors.
    Zheng X; Bauer P; Baumeister T; Buckmelter AJ; Caligiuri M; Clodfelter KH; Han B; Ho YC; Kley N; Lin J; Reynolds DJ; Sharma G; Smith CC; Wang Z; Dragovich PS; Oh A; Wang W; Zak M; Gunzner-Toste J; Zhao G; Yuen PW; Bair KW
    J Med Chem; 2013 Jun; 56(12):4921-37. PubMed ID: 23617784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological screening, and molecular docking of quinazolinone and quinazolinethione as phosphodiesterase 7 inhibitors.
    Elfeky SM; Sobahi TR; Gineinah MM; Ahmed NS
    Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900211. PubMed ID: 31696968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophilic adduction of ubiquitin activating enzyme E1 by N,N-diethyldithiocarbamate inhibits ubiquitin activation and is accompanied by striatal injury in the rat.
    Viquez OM; Caito SW; McDonald WH; Friedman DB; Valentine WM
    Chem Res Toxicol; 2012 Nov; 25(11):2310-21. PubMed ID: 22874009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective virtual screening strategy toward covalent ligands: identification of novel NEDD8-activating enzyme inhibitors.
    Zhang S; Tan J; Lai Z; Li Y; Pang J; Xiao J; Huang Z; Zhang Y; Ji H; Lai Y
    J Chem Inf Model; 2014 Jun; 54(6):1785-97. PubMed ID: 24857708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.